Novo Holdings Portfolio Holdings

Novo Holdings

  • $1.15 Billion
  • Q2 2025

Novo Holdings has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.15 Billion distributed in 29 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Vanguard Total Stock Market Et with a value of $316M, Asml Holding Nv with a value of $133M, Salesforce, Inc. with a value of $90M, Mirum Pharmaceuticals, Inc. with a value of $76.3M, and Edgewise Therapeutics, Inc. with a value of $70.1M.

Examining the 13F form we can see an increase of $35.3M in the current position value, from $1.11B to 1.15B.

Novo Holdings is based out at Hellerup, G7

Below you can find more details about Novo Holdings portfolio as well as his latest detailed transactions.

Portfolio value $1.15 Billion
Healthcare: $564 Million
ETFs: $316 Million
Technology: $226 Million
Consumer Cyclical: $42.2 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$0
$316 Million 27.52% of portfolio
1,038,550
Q2 2024 New
$295B
$133 Million 11.59% of portfolio
165,836
Q4 2024 Added 24.37%
$232B
$90 Million 7.85% of portfolio
330,187
Q2 2025 Added 21.04%
$2.38B
$76.3 Million 6.65% of portfolio
1,500,055
Q2 2025 Added 0.0%
$846M
$70.1 Million 6.11% of portfolio
5,350,000
Q1 2025 Added 7.0%
$16.5B
$68.4 Million 5.97% of portfolio
680,000
Q2 2025 Reduced 6.16%
$976M
$48.9 Million 4.26% of portfolio
9,665,128
Q1 2025 Reduced 4.44%
$1.53B
$44.6 Million 3.89% of portfolio
1,550,000
Q2 2025 Added 21.57%
$324B
$42.2 Million 3.68% of portfolio
372,327
Q1 2025 Reduced 17.69%
$2.93B
$39.5 Million 3.44% of portfolio
750,000
Q2 2025 Reduced 4.96%
$10.6B
$36.3 Million 3.16% of portfolio
660,000
Q2 2025 Added 34.69%
$7.73B
$34 Million 2.96% of portfolio
264,956
Q2 2025 Added 15.8%
$717M
$33.3 Million 2.9% of portfolio
2,380,000
Q2 2025 Added 5.76%
$712M
$30.4 Million 2.65% of portfolio
1,725,000
Q2 2024 Added 47.68%
$1.78B
$29.8 Million 2.6% of portfolio
916,160
Q2 2025 Added 0.13%
$1.11B
$24.4 Million 2.13% of portfolio
1,200,000
Q1 2025 Added 20.0%
$199M
$7.42 Million 0.65% of portfolio
2,000,000
Q2 2025 Added 2.56%
$37.7M
$4.66 Million 0.41% of portfolio
3,354,449
Q3 2024 Reduced 24.27%
$2.86B
$2.57 Million 0.22% of portfolio
441,558
Q4 2021 New
$1.22B
$2.24 Million 0.2% of portfolio
652,529
Q2 2025 Reduced 42.1%
Lanzatech Global Inc
-
$0 0.0% of portfolio
-
Q1 2023 New
Galecto Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Ceribell Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 2.27%
Brookfield Corp
-
$0 0.0% of portfolio
-
Q1 2025 Reduced 16.72%
Arrivent Biopharma Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 23.12%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
Zenas Biopharma Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 1.58%

Summary

  • Portfolio
  • No. of Stocks 29
  • Current Value $1.15 Billion
  • Prior Value $1.11 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 3 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Novo Holdings Portfolio

Follow Novo Holdings and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

News

Stay updated on Novo Holdings with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email